Essential information for estimating total PASI: A model developed from phase 3 trials of ixekizumab (IXE) for application in teledermatologyJ. Wu,H. Petto, Y. Dutronc,N. Burkhardt,M. GooderhamAUSTRALASIAN JOURNAL OF DERMATOLOGY（2018）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
